Chandra Bhagat Pharma Limited
BSE: CBPL · Pharmaceuticals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Chandra Bhagat Pharma Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Chandra Bhagat Pharma Limited is a Mumbai-based pharmaceutical company specialising in the marketing and distribution of generic and branded formulations. The firm focuses on critical care segments, including oncology, cardiovascular medicine, and antibiotics.
Business Model
The company operates as a distribution entity, procuring pharmaceutical formulations from contract manufacturers to supply hospitals, pharmacies, and government institutions. It leverages an established supply chain to manage both domestic and international distribution.
Growth Outlook
The company aims to expand its product portfolio by targeting high-demand therapeutic areas and enhancing its export capabilities in emerging global markets.
Key Risks
- Supply Chain Dependency. The company relies on third-party contract manufacturers, making it vulnerable to disruptions in production or quality control issues at partner facilities.
- Regulatory Compliance. As a pharmaceutical distributor, the company faces stringent regulatory oversight and potential changes in drug pricing policies that could impact margins.
- Market Competition. The pharmaceutical distribution sector is highly competitive, with significant pressure on pricing and the need to maintain strong relationships with healthcare providers.
- Currency and Export Risk. Expanding into international markets exposes the company to foreign exchange volatility and varying regulatory standards across different jurisdictions.
Start your research today
Unlock AI insights, financials, peers and live data on Chandra Bhagat Pharma Limited and 5,000+ companies — free.
Peers · Pharmaceuticals
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Chandra Bhagat Pharma LimitedCBPL | ₹37 Cr | — | — | — | 3.3% | — | — | +14.9% |
TranschemTRANSCHEM | ₹502 Cr | 75.62 | 52.99 | -100.0% | 177.7% | 8.3% | 10.6% | +600.8% |
Albert DavidALBERTDAVD | ₹501 Cr | 21.67 | 13.19 | 11.4% | 11.0% | 5.8% | 7.5% | +10.3% |
Haleos Labs LimitedHALEOSLABS | ₹457 Cr | 28.51 | 12.83 | -3.1% | 13.6% | 7.4% | 10.3% | — |
Medicamen BiotecMEDICAMEQ | ₹434 Cr | 43.00 | 19.76 | 24.7% | 11.3% | 4.1% | 6.2% | +5.9% |
Jenburkt Pharmaceuticals LimitedJENBURPH | ₹420 Cr | 12.30 | 8.20 | — | 30.0% | 16.7% | 21.5% | -15.2% |
As of Mar 2026
Financials
Chandra Bhagat Pharma Limited
BSE: CBPL · Pharmaceuticals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Chandra Bhagat Pharma Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Chandra Bhagat Pharma Limited is a Mumbai-based pharmaceutical company specialising in the marketing and distribution of generic and branded formulations. The firm focuses on critical care segments, including oncology, cardiovascular medicine, and antibiotics.
Business Model
The company operates as a distribution entity, procuring pharmaceutical formulations from contract manufacturers to supply hospitals, pharmacies, and government institutions. It leverages an established supply chain to manage both domestic and international distribution.
Growth Outlook
The company aims to expand its product portfolio by targeting high-demand therapeutic areas and enhancing its export capabilities in emerging global markets.
Key Risks
- Supply Chain Dependency. The company relies on third-party contract manufacturers, making it vulnerable to disruptions in production or quality control issues at partner facilities.
- Regulatory Compliance. As a pharmaceutical distributor, the company faces stringent regulatory oversight and potential changes in drug pricing policies that could impact margins.
- Market Competition. The pharmaceutical distribution sector is highly competitive, with significant pressure on pricing and the need to maintain strong relationships with healthcare providers.
- Currency and Export Risk. Expanding into international markets exposes the company to foreign exchange volatility and varying regulatory standards across different jurisdictions.
Start your research today
Unlock AI insights, financials, peers and live data on Chandra Bhagat Pharma Limited and 5,000+ companies — free.
Peers · Pharmaceuticals
As of Mar 2026